← Evidence map

ReviewOncology letters2025

The advantages and challenges of sorafenib combination therapy: Drug resistance, toxicity and future directions (Review).

Mengyan Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

9 papers cite it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 41000594